? ? The purpose of this program is to train postdoctoral investigators (3 Ph.D. and 3 M.D.) to develop skills that will allow them to become successful independent investigators, future leaders in the clinical research enterprise and mentors for the next generation of biomedical scientists. The emphasis will be upon linking the interface between immunology, molecular cell biology, genomics, and proteomics to understand the pathophysiology of human pulmonary disease. The need for this training program was recently emphasized by the NIH Roadmap initiative, calling for building interdisciplinary research teams with the intent of re-engineering the clinical research enterprise. Particular emphasis will be placed upon training investigators to use multidisciplinary approaches in attacking fundamental problems related to origins and cures for lung disease. Our training faculty were purposefully selected to provide a wide range of training environments that cross this spectrum, including molecular genetics, immune cell function, functional genomics, lung epithelial cell function, cell signaling, free radical biology, mitochondrial biology, and lung and vascular pathophysiology. Objective 1. To provide sufficient didactic, interactive and technical background in molecular biology, immunology, cell signaling, free radical biology, proteomics, and functional genomics to allow trainees to be able to move easily between these disciplines and to be able to translate their knowledge into further understanding of the origins of pulmonary disease. Objective 2. To develop an innovative program which ensures that trainees move rapidly into direct hands-on laboratory experiences. Objective 3. To immerse the trainees in a creative and positive research environment, ensuring the greatest possibility for their success and retention. In addition, specific training will be provided in the ethics and philosophy of research with the intent of producing scientists who will operate at the highest levels of intellectual integrity. Objective 4. To develop long-range programs which encourage women and minorities to pursue careers in pulmonary science and research and more importantly to build sufficient infrastructure and support systems within the training program to ensure the success of the motivated trainee. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007946-06A2
Application #
7232975
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2000-09-30
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
6
Fiscal Year
2007
Total Cost
$239,881
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Arnett, Eusondia; Weaver, Ashlee M; Woodyard, Kiersten C et al. (2018) PPAR? is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis. PLoS Pathog 14:e1007100
Locke, Landon W; Kothandaraman, Shankaran; Tweedle, Michael et al. (2018) Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108:201-210
Le, Van; Crouser, Elliott D (2018) Potential immunotherapies for sarcoidosis. Expert Opin Biol Ther 18:399-407
Jones, Christopher J; Wozniak, Daniel J (2017) Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune Evasion. MBio 8:
Pyle, Charlie J; Azad, Abul K; Papp, Audrey C et al. (2017) Elemental Ingredients in the Macrophage Cocktail: Role of ZIP8 in Host Response to Mycobacterium tuberculosis. Int J Mol Sci 18:
Ren, Li; Campbell, Amanda; Fang, Huiqing et al. (2016) Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fc? Receptor (Fc?R) Function. J Biol Chem 291:3043-52
Fatehchand, Kavin; McMichael, Elizabeth L; Reader, Brenda F et al. (2016) Interferon-? Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem 291:25656-25666
Barger, Jennifer F; Rahman, Mohammad A; Jackson, Devine et al. (2016) Extracellular miRNAs as biomarkers in cancer. Food Chem Toxicol 98:66-72
Gautam, Shalini; Fatehchand, Kavin; Elavazhagan, Saranya et al. (2016) Reprogramming Nurse-like Cells with Interferon ? to Interrupt Chronic Lymphocytic Leukemia Cell Survival. J Biol Chem 291:14356-62
Elavazhagan, Saranya; Fatehchand, Kavin; Santhanam, Vikram et al. (2015) Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity. J Immunol 194:2786-95

Showing the most recent 10 out of 30 publications